Indian vaccine giant Serum plans African plant in global expansion | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
June 12, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JUNE 12, 2025
Indian vaccine giant Serum plans African plant in global expansion

Global Economy

Reuters
24 May, 2022, 10:30 am
Last modified: 24 May, 2022, 10:39 am

Related News

  • Serum Institute, Bill Gates get Bombay high court notice as petitioner claims Covishield killed his daughter
  • India develops its first cervical cancer vaccine
  • India's Serum Institute applies for full approval of Covishield vaccine
  • Serum Institute pledges $66 million to Oxford University for research
  • Serum sends 4.5M AstraZeneca doses to Bangladesh

Indian vaccine giant Serum plans African plant in global expansion

Reuters
24 May, 2022, 10:30 am
Last modified: 24 May, 2022, 10:39 am
Photo :UNB
Photo :UNB

The Serum Institute of India (SII), the world's biggest vaccine maker, is considering setting up its first manufacturing plant in Africa as it looks to expand globally after its success in selling Covid-19 shots, its CEO told Reuters on Monday.

Africa was the only continent that did not have its own manufacturing capacity for Covid shots during the worst phases of the pandemic in the last two years, leaving it at the mercy of suppliers from overseas, including the SII.

"It's never been a better time to be a vaccine manufacturer. I'm looking at expanding our manufacturing across the globe," SII Chief Executive Adar Poonawalla said during an interview at the World Economic Forum in Davos.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"There are some great countries out there: South Africa, Rwanda, you know, to name a few that we're looking at."

Poonawalla said he was meeting some African officials in Davos to discuss his plans. Asked about possible investments, he said such projects typically required at least around $300 million.

He did not say what products an African plant might make. Apart from Covid shots, the SII's Indian plants make vaccines for diphtheria, BCG, measles, rubella and other conditions.

Asked about concerns over the rise of monkeypox cases, Poonawalla said he believed the disease was not so infectious.

"We'll wait and see even if we want to make a vaccine for it," he said.

Monkeypox is usually mild and is endemic in parts of west and central Africa. The World Health Organization has said it expects to identify more cases as it expands surveillance in countries where the disease is not typically found.

On Covid, the SII has sold more than 1.5 billion doses in India of the AstraZeneca shot it makes and brands Covishield, and exported millions more.

But as demand has now waned, the company is putting its Indian Covishield facilities on standby and will "not produce anything there", Poonawalla said, while adding it could resume output if needed.

The SII has also pulled the plug on a plan to produce and sell about 300 million doses of Russia's Sputnik Light Covid vaccine. However, it is still making millions of doses of a version of the Novavax Covid shot for India and other countries, Poonawalla said.

He estimated privately held SII was now valued at roughly $20 billion, but said there was no immediate plan to go public.

Top News / World+Biz / South Asia

Serum Institute / Serum Institute of India / Serum Institute of India (SII)

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Saifuzzaman Chowdhury. Photo: Collected
    UK crime agency now freezes assets of ex-land minister Saifuzzaman: AJ
  • Chief Adviser Muhammad Yunus speaks at the Chatham House in London on 11 June 2025. Photo: CA Press Wing
    No desire to be part of next elected govt: CA Yunus
  • File photo of BNP Standing Committee Member Amir Khasru Mahmud Chowdhury. Photo: Collected
    Khasru flies to London ahead of Yunus-Tarique meeting

MOST VIEWED

  • Illustration: Duniya Jahan/ TBS
    Forget Katy Perry, here’s Bangladesh’s Ruthba Yasmin shooting for the moon
  • A file photo of Bangladesh Bank Governor Dr Ahsan H Mansur. Photo: Collected
    'I have no relation with this': Ahsan Mansur debunks Joy’s allegations over daughter’s Dubai flat
  • Faiz Ahmad Tayeb. Photo: BSS
    Import duty on raw materials for e-bikes, lithium batteries reduced from 80% to 1% in some cases: Faiz Taiyeb
  • File photo of ex-prime minister Sheikh Hasina and her son Sajeeb Wazed Joy. Photo: Collected
    Joy spends Eid with Hasina in India: Indian media
  • Mercantile Bank withholds dividend amid Tk1,700cr provision shortfall
    Mercantile Bank withholds dividend amid Tk1,700cr provision shortfall
  • Shakil Ahmed. Photo: Collected
    DU student allegedly hangs himself following threats over old derogatory comment about Prophet on Facebook

Related News

  • Serum Institute, Bill Gates get Bombay high court notice as petitioner claims Covishield killed his daughter
  • India develops its first cervical cancer vaccine
  • India's Serum Institute applies for full approval of Covishield vaccine
  • Serum Institute pledges $66 million to Oxford University for research
  • Serum sends 4.5M AstraZeneca doses to Bangladesh

Features

Among pet birds in the country, lovebirds are the most common, and they are also the most numerous in the haat. Photo: Junayet Rashel

Where feathers meet fortune: How a small pigeon stall became Dhaka’s premiere bird market

8h | Panorama
Illustration: Duniya Jahan/ TBS

Forget Katy Perry, here’s Bangladesh’s Ruthba Yasmin shooting for the moon

1d | Features
File photo of Eid holidaymakers returning to the capital from their country homes/Rajib Dhar

Dhaka: The city we never want to return to, but always do

2d | Features
Photo collage shows political posters in Bagerhat. Photos: Jannatul Naym Pieal

From Sheikh Dynasty to sibling rivalry: Bagerhat signals a turning tide in local politics

4d | Bangladesh

More Videos from TBS

Why is Omicron XBB more contagious?

Why is Omicron XBB more contagious?

4h | TBS Stories
What did Dr. Yunus say at the Chatham House Dialogue in London?

What did Dr. Yunus say at the Chatham House Dialogue in London?

5h | TBS Today
News of The Day, 11 JUNE 2025

News of The Day, 11 JUNE 2025

6h | TBS News of the day
WB predicts worst decade for global growth since 60s

WB predicts worst decade for global growth since 60s

8h | TBS Stories
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net